Formulation Development Co-Op

Alkermes is looking for a motivated student to join our Formulation Development team. Youll work on developing oral solid dose formulations, focusing on how pharmaceutical material flow and compress, key factors in making reliable medicines.

Responsibilities

What youll do :

Study powder behavior using solid-state characterization tools

Apply solid mechanics to real formulation challenges

Use design of experiments and statistical analysis

Collaborate with scientists across teams

This co-op offers meaningful experience in pharmaceutical development and a chance to contribute to real-world projects.

Qualifications

• Currently enrolled in an undergraduate program in Chemical Engineering, Pharmaceutical Sciences, Biomedical Engineering, Mechanical Engineering, or a related field
• Minimum GPA of 3.2
• Background in pharmaceutical sciences is a plus
• Familiarity with good laboratory practices (GLP)
• Highly motivated, with strong attention to detail
• Ability to apply scientific principles to design, execute, and interpret experiments
• A collaborative mindset and strong interpersonal skills
• Excellent written and verbal communication

Preferred Qualifications :

This is a lab-based job position, and the candidate is expected to work full-time in a lab setting. The candidate should be able to work in the lab for at least four hours a day, which may involve lifting up to ten pounds.

The hourly rate for this position ranges from $25 / hr to $28 / hr. Exact compensation may vary based on skills, training, knowledge, and experience. Additional details can be found on our careers website : www.alkermes.com / careers#working-here

#LI-HB1

About Us

Why join Team Alkermes?

Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A fully-integrated, global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we are committed to pursuing great science, driven by deep compassion to make a real impact in the lives of patients. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for various neurological disorders, including narcolepsy.

Beyond our important mission of developing medicines to address unmet patient needs, we actively seek to foster a culture of diversity, inclusion and belonging throughout our business. We strive to ensure that all voices are respected and valued, recognizing that our diversity of thought, background and perspective makes us stronger. We are proud to have been recognized as an employer of choice by many national organizations, including being certified as a Great Place to Work in the U.S. in 2024, honored as a Healthiest Employer in both Ohio and Massachusetts in 2023, a Best Place for Working Parents in 2023, and to have received the Bell Seal at the Platinum level for Workplace Mental Health by Mental Health America for three consecutive years (2021-2023).

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.

PDN-9fff8e90-8568-499e-9797-9f72de57e8cb